The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins

Hussein N. Yassine, Angela M. Jackson, Chad Borges, Dean Billheimer, Hyunwook Koh, Derek Smith, Peter Reaven, Serrine S. Lau, Christoph H. Borchers

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: HDL carries a rich protein cargo and examining HDL protein composition promises to improve our understanding of its functions. Conventional mass spectrometry methods can be lengthy and difficult to extend to large populations. In addition, without prior enrichment of the sample, the ability of these methods to detect low abundance proteins is limited. Our objective was to develop a high-throughput approach to examine HDL protein composition applicable to diabetes and cardiovascular disease (CVD). Methods. We optimized two multiplexed assays to examine HDL proteins using a quantitative immunoassay (Multi-Analyte Profiling- MAP) and mass spectrometric-based quantitative proteomics (Multiple Reaction Monitoring-MRM). We screened HDL proteins using human xMAP (90 protein panel) and MRM (56 protein panel). We extended the application of these two methods to HDL isolated from a group of participants with diabetes and prior cardiovascular events and a group of non-diabetic controls. Results: We were able to quantitate 69 HDL proteins using MAP and 32 proteins using MRM. For several common proteins, the use of MRM and MAP was highly correlated (p < 0.01). Using MAP, several low abundance proteins implicated in atherosclerosis and inflammation were found on HDL. On the other hand, MRM allowed the examination of several HDL proteins not available by MAP. Conclusions: MAP and MRM offer a sensitive and high-throughput approach to examine changes in HDL proteins in diabetes and CVD. This approach can be used to measure the presented HDL proteins in large clinical studies.

Original languageEnglish (US)
Article number8
JournalLipids in Health and Disease
Volume13
Issue number1
DOIs
StatePublished - Jan 8 2014

Fingerprint

Monitoring
Proteins
Medical problems
Cardiovascular Diseases
Throughput
Chemical analysis
Immunoassay
Proteomics
Mass spectrometry
Assays
Mass Spectrometry
Atherosclerosis
Inflammation
Population

Keywords

  • Cardiovascular disease
  • Diabetes
  • High density lipoprotein
  • Multi-analyte panel
  • Multiple reaction monitoring
  • Proteomics

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins. / Yassine, Hussein N.; Jackson, Angela M.; Borges, Chad; Billheimer, Dean; Koh, Hyunwook; Smith, Derek; Reaven, Peter; Lau, Serrine S.; Borchers, Christoph H.

In: Lipids in Health and Disease, Vol. 13, No. 1, 8, 08.01.2014.

Research output: Contribution to journalArticle

Yassine, HN, Jackson, AM, Borges, C, Billheimer, D, Koh, H, Smith, D, Reaven, P, Lau, SS & Borchers, CH 2014, 'The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins', Lipids in Health and Disease, vol. 13, no. 1, 8. https://doi.org/10.1186/1476-511X-13-8
Yassine, Hussein N. ; Jackson, Angela M. ; Borges, Chad ; Billheimer, Dean ; Koh, Hyunwook ; Smith, Derek ; Reaven, Peter ; Lau, Serrine S. ; Borchers, Christoph H. / The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins. In: Lipids in Health and Disease. 2014 ; Vol. 13, No. 1.
@article{a197cc46c4344c0d805de009e57fdf5c,
title = "The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins",
abstract = "Background: HDL carries a rich protein cargo and examining HDL protein composition promises to improve our understanding of its functions. Conventional mass spectrometry methods can be lengthy and difficult to extend to large populations. In addition, without prior enrichment of the sample, the ability of these methods to detect low abundance proteins is limited. Our objective was to develop a high-throughput approach to examine HDL protein composition applicable to diabetes and cardiovascular disease (CVD). Methods. We optimized two multiplexed assays to examine HDL proteins using a quantitative immunoassay (Multi-Analyte Profiling- MAP) and mass spectrometric-based quantitative proteomics (Multiple Reaction Monitoring-MRM). We screened HDL proteins using human xMAP (90 protein panel) and MRM (56 protein panel). We extended the application of these two methods to HDL isolated from a group of participants with diabetes and prior cardiovascular events and a group of non-diabetic controls. Results: We were able to quantitate 69 HDL proteins using MAP and 32 proteins using MRM. For several common proteins, the use of MRM and MAP was highly correlated (p < 0.01). Using MAP, several low abundance proteins implicated in atherosclerosis and inflammation were found on HDL. On the other hand, MRM allowed the examination of several HDL proteins not available by MAP. Conclusions: MAP and MRM offer a sensitive and high-throughput approach to examine changes in HDL proteins in diabetes and CVD. This approach can be used to measure the presented HDL proteins in large clinical studies.",
keywords = "Cardiovascular disease, Diabetes, High density lipoprotein, Multi-analyte panel, Multiple reaction monitoring, Proteomics",
author = "Yassine, {Hussein N.} and Jackson, {Angela M.} and Chad Borges and Dean Billheimer and Hyunwook Koh and Derek Smith and Peter Reaven and Lau, {Serrine S.} and Borchers, {Christoph H.}",
year = "2014",
month = "1",
day = "8",
doi = "10.1186/1476-511X-13-8",
language = "English (US)",
volume = "13",
journal = "Lipids in Health and Disease",
issn = "1476-511X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins

AU - Yassine, Hussein N.

AU - Jackson, Angela M.

AU - Borges, Chad

AU - Billheimer, Dean

AU - Koh, Hyunwook

AU - Smith, Derek

AU - Reaven, Peter

AU - Lau, Serrine S.

AU - Borchers, Christoph H.

PY - 2014/1/8

Y1 - 2014/1/8

N2 - Background: HDL carries a rich protein cargo and examining HDL protein composition promises to improve our understanding of its functions. Conventional mass spectrometry methods can be lengthy and difficult to extend to large populations. In addition, without prior enrichment of the sample, the ability of these methods to detect low abundance proteins is limited. Our objective was to develop a high-throughput approach to examine HDL protein composition applicable to diabetes and cardiovascular disease (CVD). Methods. We optimized two multiplexed assays to examine HDL proteins using a quantitative immunoassay (Multi-Analyte Profiling- MAP) and mass spectrometric-based quantitative proteomics (Multiple Reaction Monitoring-MRM). We screened HDL proteins using human xMAP (90 protein panel) and MRM (56 protein panel). We extended the application of these two methods to HDL isolated from a group of participants with diabetes and prior cardiovascular events and a group of non-diabetic controls. Results: We were able to quantitate 69 HDL proteins using MAP and 32 proteins using MRM. For several common proteins, the use of MRM and MAP was highly correlated (p < 0.01). Using MAP, several low abundance proteins implicated in atherosclerosis and inflammation were found on HDL. On the other hand, MRM allowed the examination of several HDL proteins not available by MAP. Conclusions: MAP and MRM offer a sensitive and high-throughput approach to examine changes in HDL proteins in diabetes and CVD. This approach can be used to measure the presented HDL proteins in large clinical studies.

AB - Background: HDL carries a rich protein cargo and examining HDL protein composition promises to improve our understanding of its functions. Conventional mass spectrometry methods can be lengthy and difficult to extend to large populations. In addition, without prior enrichment of the sample, the ability of these methods to detect low abundance proteins is limited. Our objective was to develop a high-throughput approach to examine HDL protein composition applicable to diabetes and cardiovascular disease (CVD). Methods. We optimized two multiplexed assays to examine HDL proteins using a quantitative immunoassay (Multi-Analyte Profiling- MAP) and mass spectrometric-based quantitative proteomics (Multiple Reaction Monitoring-MRM). We screened HDL proteins using human xMAP (90 protein panel) and MRM (56 protein panel). We extended the application of these two methods to HDL isolated from a group of participants with diabetes and prior cardiovascular events and a group of non-diabetic controls. Results: We were able to quantitate 69 HDL proteins using MAP and 32 proteins using MRM. For several common proteins, the use of MRM and MAP was highly correlated (p < 0.01). Using MAP, several low abundance proteins implicated in atherosclerosis and inflammation were found on HDL. On the other hand, MRM allowed the examination of several HDL proteins not available by MAP. Conclusions: MAP and MRM offer a sensitive and high-throughput approach to examine changes in HDL proteins in diabetes and CVD. This approach can be used to measure the presented HDL proteins in large clinical studies.

KW - Cardiovascular disease

KW - Diabetes

KW - High density lipoprotein

KW - Multi-analyte panel

KW - Multiple reaction monitoring

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=84892160736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892160736&partnerID=8YFLogxK

U2 - 10.1186/1476-511X-13-8

DO - 10.1186/1476-511X-13-8

M3 - Article

VL - 13

JO - Lipids in Health and Disease

JF - Lipids in Health and Disease

SN - 1476-511X

IS - 1

M1 - 8

ER -